|
1
|
Ortiz MV and Dunkel IJ: Retinoblastoma. J
Child Neurol. 31:227–236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rao R and Honavar SG: Retinoblastoma.
Indian J Pediatr. 84:937–944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen BJ, Mariño-Enríquez A, Fletcher CD
and Hornick JL: Loss of retinoblastoma protein expression in
spindle cell/pleomorphic lipomas and cytogenetically related
tumors: An immunohistochemical study with diagnostic implications.
Am J Surg Pathol. 36:1119–1128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tetzlaff JE: The pharmacology of local
anesthetics. Anesthesiol Clin North Am. 18:217–233. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caracas HC, Maciel JV, Martins PM, de
Souza MM and Maia LC: The use of lidocaine as an anti-inflammatory
substance: A systematic review. J Dent. 37:93–97. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adler DMT, Damborg P and Verwilghen DR:
The antimicrobial activity of bupivacaine, lidocaine and
mepivacaine against equine pathogens: An investigation of 40
bacterial isolates. Vet J. 223:27–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao X, Yang H, Wu M, Shi K, Zhou C, Peng J
and Yang Q: Targeting delivery of lidocaine and cisplatin by
nanogel enhances chemotherapy and alleviates metastasis. ACS Appl
Mater Interfaces. 10:25228–25240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnson MZ, Crowley PD, Foley AG, Xue C,
Connolly C, Gallagher HC and Buggy DJ: Effect of perioperative
lidocaine on metastasis after sevoflurane or ketamine-xylazine
anaesthesia for breast tumour resection in a murine model. Br J
Anaesth. 121:76–85. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ro S, Park C, Young D, Sanders KM and Yan
W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res.
35:5944–5953. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mallory AC and Vaucheret H: MicroRNAs:
Something important between the genes. Curr Opin Plant Biol.
7:120–125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu N, Song Y, Pang L and Chen Z: CRCT1
regulated by microRNA-520 g inhibits proliferation and induces
apoptosis in esophageal squamous cell cancer. Tumor Biol.
37:8271–8279. 2016. View Article : Google Scholar
|
|
16
|
Keklikoglou I, Koerner C, Schmidt C, Zhang
JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T,
Schneeweiss A, et al: MicroRNA-520/373 family functions as a tumor
suppressor in estrogen receptor negative breast cancer by targeting
NF-κB and TGF-β signaling pathways. Oncogene. 31:4150–4163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding M, Lu X, Wang C, Zhao Q, Ge J, Xia Q,
Wang J, Zen K, Zhang CY and Zhang C: The E2F1-miR-520/372/373-SPOP
axis modulates progression of renal carcinoma. Cancer Res.
78:6771–6784. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park YY, Kim SB, Han HD, Sohn BH, Kim JH,
Liang J, Lu Y, Rodriguez-Aguayo C, Lopez-Berestein G, Mills GB, et
al: Tat-activating regulatory DNA-binding protein regulates
glycolysis in hepatocellular carcinoma by regulating the platelet
isoform of phosphofructokinase through microRNA 520. Hepatology.
58:182–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang R, Liu R, Liu C, Niu Y, Zhang J, Guo
B, Zhang CY, Li J, Yang J and Chen X: A novel role for MiR-520a-3p
in regulating EGFR expression in colorectal cancer. Cell Physiol
Biochem. 42:1559–1574. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Miao L, Ni R, Zhang H, Li L, Wang
X, Li X and Wang J: microRNA-520a-3p inhibits proliferation and
cancer stem cell phenotype by targeting HOXD8 in non-small cell
lung cancer. Oncol Rep. 36:3529–3535. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen A, Xu J and Johnson AC: Curcumin
inhibits human colon cancer cell growth by suppressing gene
expression of epidermal growth factor receptor through reducing the
activity of the transcription factor Egr-1. Oncogene. 25:278–287.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cîrstea AE, Stepan AE, Zăvoi RE and
Simionescu CE: EGFR Immunoexpression in malignant serous and
mucinous ovarian tumors. Curr Health Sci J. 44:129–134.
2018.PubMed/NCBI
|
|
23
|
Jia Y, Li X, Jiang T, Zhao S, Zhao C,
Zhang L, Liu X, Shi J, Qiao M, Luo J, et al: EGFR-targeted therapy
alters the tumor microenvironment in EGFR-driven lung tumors:
Implications for combination therapies. Int J Cancer. Feb
5–2019.doi: 10.1002/ijc.32191 (Epub ahead of print). View Article : Google Scholar
|
|
24
|
Wang P, Liu X, Shao Y, Wang H, Liang C,
Han B and Ma Z: MicroRNA-107-5p suppresses non-small cell lung
cancer by directly targeting oncogene epidermal growth factor
receptor. Oncotarget. 8:57012–57023. 2017.PubMed/NCBI
|
|
25
|
Sakaguchi M, Kuroda Y and Hirose M: The
antiproliferative effect of lidocaine on human tongue cancer cells
with inhibition of the activity of epidermal growth factor
receptor. Anesth Analg. 102:1103–1107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bundscherer AC, Malsy M, Bitzinger DI,
Wiese CH, Gruber MA and Graf BM: Effects of lidocaine on HT-29 and
SW480 colon cancer cells in vitro. Anticancer Res. 37:1941–1945.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qu X, Yang L, Shi Q, Wang X, Wang D and Wu
G: Lidocaine inhibits proliferation and induces apoptosis in
colorectal cancer cells by upregulating mir-520a-3p and targeting
EGFR. Pathol Res Pract. 214:1974–1979. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American physiological
society. Physiologist. 39:199, 208–211. 1996.
|
|
30
|
Freeman J, Crowley PD, Foley AG, Gallagher
HC, Iwasaki M, Ma D and Buggy DJ: Effect of perioperative lidocaine
and cisplatin on metastasis in a murine model of breast cancer
surgery. Anticancer Res. 38:5599–5606. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Zhu X, Zhu X, Wu Y, Liu Y, Yao B
and Huang Z: MiR-613 suppresses retinoblastoma cell proliferation,
invasion, and tumor formation by targeting E2F5. Tumour Biol.
39:10104283176916742017.PubMed/NCBI
|
|
32
|
Di LG and Croce CM: miRNA profiling of
cancer. Curr Opin Genet Dev. 23:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei W, Yang Y, Cai J, Cui K, Li RX, Wang
H, Shang X and Wei D: MiR-30a-5p Suppresses tumor metastasis of
human colorectal cancer by targeting ITGB3. Cell Physiol Biochem.
39:1165–1176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu X, Xie T, Mao X, Xue L, Chu X and Chen
L: MicroRNA-149 increases the sensitivity of colorectal cancer
cells to 5-fluorouracil by targeting forkhead box transcription
factor FOXM1. Cell Physiol Biochem. 39:617–629. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou L, Xu Z, Ren X, Chen K and Xin S:
MicroRNA-124 (MiR-124) inhibits cell proliferation, metastasis and
invasion in colorectal cancer by downregulating Rho-associated
protein kinase 1(ROCK1). Cell Physiol Biochem. 38:1785–1795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li HT, Zhang H, Chen Y, Liu XF and Qian J:
MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1
in colorectal cancer. Cell Physiol Biochem. 37:1044–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nishimura M, Jung EJ, Shah MY, Lu C,
Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X, et al:
Therapeutic synergy between microRNA and siRNA in ovarian cancer
treatment. Cancer Discov. 3:1302–1315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li R, Yuan W, Mei W, Yang K and Chen Z:
MicroRNA 520d-3p inhibits gastric cancer cell proliferation,
migration, and invasion by downregulating EphA2 expression. Mol
Cell Biochem. 396:295–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gach K, Wyrębska A, Fichna J and Janecka
A: The role of morphine in regulation of cancer cell growth. Naunyn
Schmiedebergs Arch Pharmacol. 384:221–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu YB, Du QH, Zhang MY, Yun P and He CY:
Propofol suppresses proliferation, invasion and angiogenesis by
down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal
squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci.
17:2486–2494. 2013.PubMed/NCBI
|
|
41
|
Chang YC, Liu CL, Chen MJ, Hsu YW, Chen
SN, Lin CH, Chen CM, Yang FM and Hu MC: Local anesthetics induce
apoptosis in human breast tumor cells. Anesth Analg. 118:116–124.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu J, Tan Q, Deng B, Fang C, Qi D and Wang
R: The microRNA-520a-3p inhibits proliferation, apoptosis and
metastasis by targeting MAP3K2 in non-small cell lung cancer. Am J
Cancer Res. 5:802–811. 2015.PubMed/NCBI
|
|
43
|
Li J, Wei J, Mei Z, Yin Y, Li Y, Lu M and
Jin S: Suppressing role of miR-520a-3p in breast cancer through
CCND1 and CD44. Am J Transl Res. 9:146–154. 2017.PubMed/NCBI
|
